VIM and diabetic kidney disease: To further study the phenotypic changes associated with gain of vimentin and loss of HNF4A in kidneys affected by crescentic glomerulonephritis and diabetic nephropathy (Figure 3, A and E), colocalization of VIM with a general mitochondrial marker was performed.